_PRIVATE_LIMITED.webp)
Aswini Health Specialities (India) Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-07-2024
- Paid Up Capital ₹ 5.00 M
as on 24-07-2024
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 48.59 M
as on 24-07-2024
- Satisfied Charges ₹ 53.85 M
as on 24-07-2024
- Revenue 19.24%
(FY 2023)
- Profit -22.15%
(FY 2023)
- Ebitda 5.20%
(FY 2023)
- Net Worth 24.99%
(FY 2023)
- Total Assets 15.16%
(FY 2023)
About Aswini Health Specialities (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.86 Cr. The company has closed loans amounting to ₹5.39 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kshemavilas Santhakumar and Manoj Anandan serve as directors at the Company.
- CIN/LLPIN
U52310KL2007PTC020905
- Company No.
020905
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kalamassery, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aswini Health Specialities (India)?
Executive Team (1)
KS
Kshemavilas Santhakumar
Managing DirectorAppointment Date: 08-Jun-2007
Status: Current
Board Members(1)
Financial Performance and Corporate Structure Insights of Aswini Health Specialities (India).
Aswini Health Specialities (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.24% increase. The company also saw a substantial fall in profitability, with a 22.15% decrease in profit. The company's net worth Soared by an impressive increase of 24.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aswini Health Specialities (India)?
In 2023, Aswini Health Specialities (India) had a promoter holding of 82.06% and a public holding of 17.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
1 year 7 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Mar 2024 | ₹5.00 M | Open |
Others Creation Date: 21 Sep 2023 | ₹1.02 M | Open |
Others Creation Date: 30 Nov 2022 | ₹4.00 Cr | Open |
How Many Employees Work at Aswini Health Specialities (India)?
Unlock and access historical data on people associated with Aswini Health Specialities (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 31, 2023, Aswini Health Specialities (India) has raised a total of ₹ 0.78 M, with the most recent deal valued at ₹ 0.33 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
